Assignee
ATRIVA THERAPEUTICS GMBH
DE·4 granted patents·9 pending applications·4 citations·filing 2015–2024
Top patents by PatentIndex Score
13 records- 0176US11903917B2MEK-inhibitor for the treatment of viral and bacterial infectionsATRIVA THERAPEUTICS GMBH·Filed 2018·Granted Feb 20, 2024·2 cites·18 claims
- 0274US10456440B2Anti-infective strategy against influenza virus and S. aureus coinfectionsATRIVA THERAPEUTICS GMBH·Filed 2015·Granted Oct 29, 2019·2 cites·15 claims
- 0367US2024245637A1Mek-inhibitor for the treatment of viral and bacterial infectionsATRIVA THERAPEUTICS GMBH·Filed 2024·Application pending·0 cites
- 0463US2022096590A1Novel-anti-infective strategy against influenza virus and s. aureus coinfectionsATRIVA THERAPEUTICS GMBH·Filed 2021·Application pending·0 cites
- 0561US11135263B2Novel-anti-infective strategy against influenza virus and S. aureus coinfectionsATRIVA THERAPEUTICS GMBH·Filed 2019·Granted Oct 5, 2021·0 cites·15 claims
- 0653US12350244B2MEK-inhibitor for the treatment of viral and bacterial infectionsATRIVA THERAPEUTICS GMBH·Filed 2020·Granted Jul 8, 2025·0 cites·23 claims
- 0751US2023241014A1Mek-inhibitors for the treatment or prevention of coronavirus infections and/or covid-19 cytokine stormATRIVA THERAPEUTICS GMBH·Filed 2021·Application pending·0 cites
- 0850US2022152080A1Rsk inhibitors in the treatment of virus diseasesATRIVA THERAPEUTICS GMBH·Filed 2020·Application pending·0 cites
- 0949US2017209450A1Mek inhibitors in the treatment of virus diseasesATRIVA THERAPEUTICS GMBH·Filed 2017·Application pending·0 cites
- 1046US2022378730A1Mek inhibitors for the treatment of hantavirus infectionsATRIVA THERAPEUTICS GMBH·Filed 2020·Application pending·0 cites
- 1146US2022370384A1Combinations of mek inhibitors with cap-dependent endonuclease inhibitorsATRIVA THERAPEUTICS GMBH·Filed 2020·Application pending·0 cites
- 1245US2019298669A1Ci-1040 for the treatment of viral diseasesATRIVA THERAPEUTICS GMBH·Filed 2019·Application pending·0 cites
- 1338US2023172944A1Rock inhibitors for use in treating or preventing pulmonary edemaATRIVA THERAPEUTICS GMBH·Filed 2021·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →